329 related articles for article (PubMed ID: 14737850)
1. [Anti-inflammatory effect of HMG-CoA reductase inhibitors].
Kitamoto S; Egashira K
Nihon Rinsho; 2004 Jan; 62(1):172-9. PubMed ID: 14737850
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
März W; Köenig W
J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of HMG-CoA reductase inhibitors.
Bocan TM
Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
[TBL] [Abstract][Full Text] [Related]
4. Early vascular benefits of statin therapy.
Tsiara S; Elisaf M; Mikhailidis DP
Curr Med Res Opin; 2003; 19(6):540-56. PubMed ID: 14594527
[TBL] [Abstract][Full Text] [Related]
5. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
7. How do statins control neuroinflammation?
Adamson P; Greenwood J
Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis.
Kuwahara N; Sasaki S; Kobara M; Nakata T; Tatsumi T; Irie H; Narumiya H; Hatta T; Takeda K; Matsubara H; Hushiki S
Int J Cardiol; 2008 Jan; 123(2):84-90. PubMed ID: 17434618
[TBL] [Abstract][Full Text] [Related]
10. Statins: a treatment option for chronic heart failure?
von Haehling S; Okonko DO; Anker SD
Heart Fail Monit; 2004; 4(3):90-7. PubMed ID: 15772704
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
Patrick L; Uzick M
Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
[TBL] [Abstract][Full Text] [Related]
12. The beneficial effects of statins in autoimmune disease therapy.
Marai I; Shoenfeld Y
Drug News Perspect; 2007 Apr; 20(3):165-9. PubMed ID: 17520093
[TBL] [Abstract][Full Text] [Related]
13. Statins: multiple mechanisms of action in the ischemic brain.
Cimino M; Gelosa P; Gianella A; Nobili E; Tremoli E; Sironi L
Neuroscientist; 2007 Jun; 13(3):208-13. PubMed ID: 17519364
[TBL] [Abstract][Full Text] [Related]
14. [Statins in the management of acute coronary syndrome].
Matoba T; Egashira K
Nihon Rinsho; 2010 Apr; 68(4):692-8. PubMed ID: 20387563
[TBL] [Abstract][Full Text] [Related]
15. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.
Arnaud C; Burger F; Steffens S; Veillard NR; Nguyen TH; Trono D; Mach F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1231-6. PubMed ID: 15790934
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory effects of statins and autoimmune rheumatic diseases: novel intracellular mechanism involved.
Tristano AG; Fuller K
Int Immunopharmacol; 2006 Dec; 6(12):1833-46. PubMed ID: 17052674
[TBL] [Abstract][Full Text] [Related]
17. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
18. [Anti-inflammatory mechanism of statins in atherosclerosis management].
Zhao SP
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2818-20. PubMed ID: 16324336
[No Abstract] [Full Text] [Related]
19. Statins and stroke.
Endres M
J Cereb Blood Flow Metab; 2005 Sep; 25(9):1093-110. PubMed ID: 15815580
[TBL] [Abstract][Full Text] [Related]
20. Essential fatty acids as possible mediators of the actions of statins.
Das UN
Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):37-40. PubMed ID: 11487306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
